摘要:
The invention concerns the use of the salts of the L-(-)-enantiomer of (endo, syn)-(-)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(methylethyl)-8-azoniabicyclo[3.2.1] octane as active substances for medicaments administered by inhalation for treatment of the respiratory tract. These salts are suitable for such treatment owing to their unexpectedly intense and prolonged effect.
摘要:
The invention relates to novel medicament compositions, based on anticholinergic compounds and beta-mimetics which are effective on a long-term basis. The invention also relates to a method for producing the same and to their use in the treatment of diseases of the respiratory tract.
摘要:
The present invention relates to novel pharmaceutical compositions based on PDE IV inhibitors and salts of a new anticholinergic, processes for preparing them and their use in the treatment of respiratory complaints.
摘要:
The invention concerns the use of the salts of the L-(-)-enantiomer of (endo, syn)-(-)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(methylethyl)-8-azoniabicyclo[3.2.1] octane as active substances for medicaments administered by inhalation for treatment of the respiratory tract. These salts are suitable for such treatment owing to their unexpectedly intense and prolonged effect.
摘要:
The present invention relates to novel pharmaceutical compositions based on steroids and salts of a new anticholinergic, processes for preparing them and their use in the treatment of respiratory complaints.
摘要:
The present invention relates to novel pharmaceutical compositions based on beta2 agonists and salts of a new anticholinergic, processes for preparing them and their use in the treatment of respiratory complaints, wherein the anticholinergic agent has the formula (I).
摘要:
De nouveaux composés répondant à la formule (I): AO-CO-Z, dans laquelle A et Z ont la signification donnée dans la description, peuvent être préparés selon des méthodes classiques; ils sont utiles comme substances actives dans des médicaments.